INITIAL PHASE-II CLINICAL-STUDIES ON MIDAGLIZOLE (DG-5128) - A NEW HYPOGLYCEMIC AGENT

[1] FIELD M, 1973, AM J PHYSIOL, V225, P852

[2] KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262

[3] INSULIN RELEASING ACTION OF 2-[2-(4,5-DIHYDRO-1H-IMADAZOL-2-YL)-1-PHENYLETHYL] PYRIDINE DIHYDROCHLORIDE SESQUIHYDRATE (DG-5128), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT [J]. ACTA ENDOCRINOLOGICA, 1982, 99 (03): : 410 - 415

[4] KAMEDA K, 1982, ARZNEIMITTEL-FORSCH, V32-1, P39

[5] KAMEDA KY, 1981, BIOCHIM BIOPHYS ACTA, V677, P263

[6] KAWAZU S, 1984, Journal of the Japan Diabetes Society, V27, P803

[7] STUDIES OF MIDAGLIZOLE (DG-5128) - A NEW TYPE OF ORAL HYPOGLYCEMIC DRUG IN HEALTHY-SUBJECTS [J]. DIABETES, 1987, 36 (02) : 216 - 220

[8] KNUDTZON J, 1983, DIABETOLOGIA, V25, P171

[9] INSULIN-LIKE ACTIVITY IN PANCREATIC VEIN BLOOD AFTER GLUCOSE LOADING + EPINEPHRINE HYPERGLYCEMIA [J]. ENDOCRINOLOGY, 1964, 75 (01) : 9 - &

[10] Kosaka K, 1982, J JAPAN DIAB SOC, V25, P859

[1] FIELD M, 1973, AM J PHYSIOL, V225, P852

[2] KADOWAKI T, 1984, DIABETOLOGIA, V26, P44, DOI 10.1007/BF00252262

[3] INSULIN RELEASING ACTION OF 2-[2-(4,5-DIHYDRO-1H-IMADAZOL-2-YL)-1-PHENYLETHYL] PYRIDINE DIHYDROCHLORIDE SESQUIHYDRATE (DG-5128), A NEW, ORALLY EFFECTIVE HYPOGLYCEMIC AGENT [J]. ACTA ENDOCRINOLOGICA, 1982, 99 (03): : 410 - 415

[4] KAMEDA K, 1982, ARZNEIMITTEL-FORSCH, V32-1, P39

[5] KAMEDA KY, 1981, BIOCHIM BIOPHYS ACTA, V677, P263

[6] KAWAZU S, 1984, Journal of the Japan Diabetes Society, V27, P803

[7] STUDIES OF MIDAGLIZOLE (DG-5128) - A NEW TYPE OF ORAL HYPOGLYCEMIC DRUG IN HEALTHY-SUBJECTS [J]. DIABETES, 1987, 36 (02) : 216 - 220

[8] KNUDTZON J, 1983, DIABETOLOGIA, V25, P171

[9] INSULIN-LIKE ACTIVITY IN PANCREATIC VEIN BLOOD AFTER GLUCOSE LOADING + EPINEPHRINE HYPERGLYCEMIA [J]. ENDOCRINOLOGY, 1964, 75 (01) : 9 - &

[10] Kosaka K, 1982, J JAPAN DIAB SOC, V25, P859